News

November 10, 2017

National Business Review 13th October 2017

Dr Ruth Appleby presents at NZ BIO Conference.

See report on Upstream Medical Technologies presentation at the NZBIO Conference in Wellington, New Zealand on 13th October 2017.

Click here to download the report

Share this post

More Articles

Detecting at-risk heart attack patients, a step closer with $2m investment

Upstream Medical Technologies, a leading deep-tech company focused on developing innovative solutions for heart disease, announced today that it has closed a significant capital round to further advance its frontline diagnostic tests for cardiac diseases.

Upstream commences testing Marker C on the APACE cohort

The next phase of development is now underway, with the commencement of testing Marker C on the APACE cohort.

December 12, 2022

Analysis of Marker C in clinical triage protocols available

By shifting chest pain patients with intermediate troponins to low or high-risk categories, Marker C could rapidly triage 10-35% more chest pain patients in the emergency department.

Connect with us

info@upstreamdx.com

Auckland, New Zealand